William A. Linton's most recent trade in Bruker Corp was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 22 Apr 2025 | 10,000 | 58,723 (0%) | 0% | 24 | 240,000 | Common Stock |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 3,298 | 48,723 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 22 Nov 2024 | 10,000 | 45,425 (0%) | 0% | 19.1 | 191,200 | Common Stock |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,377 | 35,425 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.07 per share. | 05 Dec 2023 | 10,000 | 33,048 (0%) | 0% | 19.1 | 190,700 | Common Stock |
| Bruker Corp | Linton William A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,970 | 23,048 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.42 per share. | 06 Dec 2022 | 10,000 | 21,078 (0%) | 0% | 16.4 | 164,200 | Common Stock |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 1,841 | 11,078 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 6,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.77 per share. | 02 Nov 2021 | 6,000 | 9,237 (0%) | 0% | 12.8 | 76,620 | Common Stock |
| Bruker Corp | William A. Linton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Sep 2021 | 84,472 | 3,237 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 2,302 | 87,709 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 6,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.09 per share. | 09 Nov 2020 | 6,000 | 85,407 (0%) | 0% | 16.1 | 96,540 | Common Stock |